Omnitrope is a brand-name injectable solution prescribed for growth hormone deficiency in adults and children. It contains the active ingredient somatropin. Omnitrope may not be safe to receive during ...

The FDA has approved Sandoz’s Omnitrope Pen 10 (somatropin [rDNA origin] injection) for the treatment of growth failure in children and growth hormone deficiency in adults. This 10mg dosage strength ...

Sandoz (Holzkirchen, Germany), the generics arm of Novartis (Basel, Switzerland), received approval from the US Food and Drug Administration (Rockville, MD) for "Omnitrope" (somatropin [rDNA origin]), ...

Sandoz introduced its "Omnitrope Pen 5" with liquid cartridge in the United States. The product was approved by the US Food and Drug Administration and is a new form of the first follow-on version of ...

Omnitrope has possible interactions with some other drugs, such as diabetes medications. It also isn’t prescribed if you have certain health conditions. Talk with your doctor to avoid potentially ...